Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations
2020
ABSTRACTIntroduction: Cancer immunotherapy has revolutionized the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC). However, specific patient groups (e.g. patien...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
73
References
17
Citations
NaN
KQI